Skip to content
10-Q

Quarterly Report

VIGIL NEUROSCIENCE, INC.

0000950170-25-065000

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 46.67M sh
Shares Diluted Q1 2025 · Mar 31, 2025 46.07M sh
Shares Diluted Q1 2025 · Mar 31, 2024 39.86M sh
Capex Q1 2025 · Mar 31, 2025 $285K
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$23.89M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$21.88M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $51.62M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $39.02M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $51.76M
Stockholders Equity Q1 2025 · Mar 31, 2025 $65.12M
Stockholders Equity Q1 2025 · Dec 31, 2024 $71.64M
Stockholders Equity Q1 2025 · Mar 31, 2024 $103.78M
Stockholders Equity Q1 2025 · Dec 31, 2023 $116.25M
Current Liabilities Q1 2025 · Mar 31, 2025 $30.4M
Current Liabilities Q1 2025 · Dec 31, 2024 $34.15M
Total Liabilities Q1 2025 · Mar 31, 2025 $42.03M
Total Liabilities Q1 2025 · Dec 31, 2024 $46.06M
Current Assets Q1 2025 · Mar 31, 2025 $90.15M
Current Assets Q1 2025 · Dec 31, 2024 $100.58M
Total Assets Q1 2025 · Mar 31, 2025 $107.15M
Total Assets Q1 2025 · Dec 31, 2024 $117.69M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.49
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.50
Eps Basic Q1 2025 · Mar 31, 2025 −$0.49
Eps Basic Q1 2025 · Mar 31, 2024 −$0.50
Sga Expense Q1 2025 · Mar 31, 2025 $6.96M
Sga Expense Q1 2025 · Mar 31, 2024 $7.09M
Rd Expense Q1 2025 · Mar 31, 2025 $16.51M
Rd Expense Q1 2025 · Mar 31, 2024 $14.33M
Net Income Q1 2025 · Mar 31, 2025 −$22.41M
Net Income Q1 2025 · Mar 31, 2024 −$19.94M
Operating Income Q1 2025 · Mar 31, 2025 −$23.47M
Operating Income Q1 2025 · Mar 31, 2024 −$21.42M